Advertisement
YOU ARE HERE: LAT HomeCollectionsRadiance Medical Inc
IN THE NEWS

Radiance Medical Inc

FEATURED ARTICLES
BUSINESS
July 21, 2000
The Irvine medical products company said its net loss for the second quarter narrowed to $1.2 million, or 10 cents a share, from $2 million, or 18 cents a share, for the like period last year. Revenue rose 39% to $2.5 million.
ARTICLES BY DATE
BUSINESS
May 3, 2001
The Irvine medical products maker reported a first-quarter net loss of $3.2 million, or 25 cents a share, compared with net income of $1.4 million, or 13 cents a share, for the first quarter of 2000. Revenue declined 17% to $2 million.
Advertisement
BUSINESS
January 15, 1999
CardioVascular Dynamics Inc.'s proposed acquisition of Radiance Medical Systems Inc. has been approved by shareholders of the biomedical firms, the companies said. The combined Irvine-based company will be named Radiance Medical and its stock is scheduled to begin trading Jan. 25 on the Nasdaq market under the symbol RADX. Radiance, once a unit of CardioVascular, was spun off in 1997 to develop technology that uses radioactive drugs to treat vascular diseases.
BUSINESS
January 15, 1999
CardioVascular Dynamics Inc.'s proposed acquisition of Radiance Medical Systems Inc. has been approved by shareholders of the biomedical firms, the companies said. The combined Irvine-based company will be named Radiance Medical and its stock is scheduled to begin trading Jan. 25 on the Nasdaq market under the symbol RADX. Radiance, once a unit of CardioVascular, was spun off in 1997 to develop technology that uses radioactive drugs to treat vascular diseases.
BUSINESS
March 8, 2000
Radiance Medical Systems Inc. said Tuesday it has been granted four new patents for a variety of features in the Irvine company's catheter products. The stock, which has more than doubled so far this year, closed at $10.25, down 25 cents a share.
BUSINESS
May 2, 1999
Radiance Medical Systems Inc.: The Irvine medical products company reported a first-quarter net loss of $6.3 million, or 60 cents a share, which included a one-time charge of $4.2 million related to an acquisition. A year ago, the company lost $2 million, or 22 cents a share. Revenue was down 28% to $1.8 million from $2.5 million.
Los Angeles Times Articles
|